Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Entera Bio (ENTX) Return on Equity (2019 - 2025)

Entera Bio has reported Return on Equity over the past 7 years, most recently at 0.01% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 1.0% year-over-year to 0.01%, compared with a TTM value of 0.01% through Dec 2025, up 1.0%, and an annual FY2025 reading of 0.01%, changed 0.0% over the prior year.
  • Return on Equity came in at 0.01% for Q4 2025, down from 0.01% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.0% in Q4 2021 to a low of 0.01% in Q1 2021.
  • Median Return on Equity over the past 5 years was 0.01% (2022), compared with a mean of 0.01%.
  • The largest YoY upside for Return on Equity was 1bps in 2021 against a maximum downside of -3bps in 2021.
  • Over 5 years, Return on Equity stood at 0.0% in 2021, then tumbled by -101bps to 0.01% in 2022, then dropped by -7bps to 0.01% in 2023, then dropped by -24bps to 0.01% in 2024, then skyrocketed by 39bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for ENTX's Return on Equity are 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025).